日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL

在伊布替尼耐药的慢性淋巴细胞白血病(CLL)中对Hsp90抑制剂SNX-5422进行临床前评估

Chen, Timothy L; Harrington, Bonnie; Truxall, Jean; Wasmuth, Ronni; Prouty, Alexander; Sloan, Shelby; Lehman, Amy M; Sampath, Deepa; Orlemans, Eric; Baiocchi, Robert A; Alinari, Lapo; Byrd, John C; Woyach, Jennifer A; Hertlein, Erin

Phase 1 multicenter study of the HSP90 inhibitor SNX-5422 plus carboplatin and paclitaxel in patients with lung cancers

一项针对肺癌患者的 HSP90 抑制剂 SNX-5422 联合卡铂和紫杉醇的 1 期多中心研究

Gutierrez, Martin; Guo, Robin; Giaccone, Giuseppe; Liu, Stephen V; Hao, Zhonglin; Hilton, Christie; Hinson, James M Jr; Kris, Mark G; Orlemans, Everardus Otto; Drilon, Alexander